Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06881394 · ClinicalTrials.gov registry record · NA
A Polymer Film Device to Treat Excessive Palmar Sweating
A NA study of Palmar Hyperhidrosis, sponsored by Miller Biosciences.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06881394 is a NA study of Palmar Hyperhidrosis that is actively recruiting participants, run by Miller Biosciences. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06881394, a NA study of Palmar Hyperhidrosis, is actively recruiting participants, sponsored by Miller Biosciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Perspiration or sweating is a normal physiological response to increased body temperature, environmental heat and humidity, emotions, nervousness, or physical exertion. Perspiration occurs when sweat is secreted from sweat glands, travels through sweat ducts and exits sweat pores to coat the skin's surface. The evaporation of sweat from the skin dissipates heat and is the primary thermoregulatory mechanism used by humans and primates. Excessive sweating beyond what is required for maintaining body temperature homeostasis is termed hyperhidrosis. Primary hyperhidrosis is idiopathic affecting the palmar, plantar, axillary, or craniofacial regions bilaterally, while secondary hyperhidrosis is less common and is often a side effect of medication or an underlying pathology. Primary hyperhidrosis may affect up to 4.8% of the US population, yet it is widely underreported and undertreated. Hyperhidrosis can negatively impact daily activities, cause significant stress, limit social interactions, and reduce the quality of life for patients. In particular, excessive palmar sweating interferes with professional activities (e.g., shaking hands, working with tools, or wearing exam gloves) and degrades sports performance. Hyperhidrosis (HH) is especially difficult to treat on the hands and feet, with clinical care beginning with prescription strength topical aluminum chloride hexahydrate antiperspirants such as DrySol or Secret Clinical, and OTC products (e.g., Carpe). However, prescription strength aluminum chloride antiperspirants are often ineffective, can be irritating and leave a residue that degrades skin texture and grip. Currently, iontophoresis is the only medical device approved for treating palmar and plantar HH, but these devices are expensive (\~$1,500), uncomfortable to use and are time consuming (30 minutes sessions, 3-4 times a week for several months). Oral anticholinergic medicines such as oxybutynin are often prescribed but they have unwanted side effects inclu
Conditions Studied
Interventions
- DEVICE Polymer Skin Barrier
Study Locations (1)
Texas
- UTHealth McGovern Medical School-Houston and Children's Memorial Hermann Hospital-Houston, 6500 West Loop South, Suite 200-A Texas - Bellaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-07-03 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06881394
The ClinicalTrials.gov registry entry for NCT06881394 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Miller Biosciences, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Palmar Hyperhidrosis appearing as the primary indexed condition, and to 1 intervention - of which Polymer Skin Barrier is the first listed.
NCT06881394 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06881394 about?
NCT06881394 is a clinical study titled "A Polymer Film Device to Treat Excessive Palmar Sweating". Perspiration or sweating is a normal physiological response to increased body temperature, environmental heat and humidity, emotions, nervousness, or physical exertion. Perspiration occurs when sweat is secreted from sweat glands, travels through sweat ducts and exits sweat pores to coat the skin's ...
What is the current status of trial NCT06881394?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-07-03. Estimated completion is 2025-08-31.
What conditions does trial NCT06881394 study?
This clinical trial studies the following conditions: Palmar Hyperhidrosis.
What interventions are being tested in trial NCT06881394?
The interventions under investigation include: Polymer Skin Barrier (DEVICE).
Who is sponsoring clinical trial NCT06881394?
This trial is sponsored by Miller Biosciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06881394 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Palmar Hyperhidrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.